PiSA Pharmaceutical
PiSA Pharmaceutical is a Mexican pharmaceutical manufacturer operating 14 production plants, employing approximately 30,000 people, and producing 1,500+ medication brands across 17 specialty lines for government, private hospital, and pharmacy channels in Mexico and Latin America.
- Company typePrivate
- Founded1945
- HeadquartersGuadalajara, Mexico
- Headcount5,001–10,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What PiSA Pharmaceutical does
PiSA Pharmaceutical (Laboratorios PiSA, S.A. de C.V.) is a privately held Mexican pharmaceutical company headquartered in Guadalajara, Jalisco, and founded in 1945 by Professor Miguel Álvarez Ochoa. The company operates 14 production plants strategically located across Mexico, supported by a multidisciplinary workforce of approximately 30,000 collaborators, and manufactures more than 1,500 medication brands across 17 specialty lines spanning injectable solutions, penicillin and cephalosporin antibiotics, lyophilized products, dental anesthetics, oral dosage forms, immunosuppressants, biotechnology products (vials, pre-filled syringes, cartridges), medical devices, and veterinary products. Internal IT and operational controls run on SAP, with manufacturing facilities compliant with COFEPRIS, INVIMA, and FDA (Medical Devices) GMP standards.
PiSA Pharmaceutical firmographics
Firmographics- Name
- PiSA Pharmaceutical
- Legal name
- Laboratorios PiSA, S.A. de C.V.
- Website
- https://pisa.com.mx
- Company type
- Private
- Founded year
- 1945
- Operating status
- Operating
- Headcount range
- 5,001–10,000 employees
- Short description
- PiSA Pharmaceutical is a Mexican pharmaceutical manufacturer operating 14 production plants, employing approximately 30,000 people, and producing 1,500+ medication brands across 17 specialty lines for government, private hospital, and pharmacy channels in Mexico and Latin America.
- Ownership category
- akta.pro rank
PiSA Pharmaceutical industry classification
Industry- Product category
- Pharmaceutical Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254), Biological Product (except Diagnostic) Manufacturing (325414), Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)
- akta.pro secondary industries
- Generic ANDA/Regulatory Affairs & Submissions (HLAIABAJ), Compounding Pharmacies (Sterile/Non-Sterile) (HLAFALAE), Pharmaceutical Labels & Patient Information Packaging (Labels, IFUs, Booklets) (IMALAIAK)
Keywords
Where PiSA Pharmaceutical is headquartered
LocationHeadquarters
- HQ city
- Guadalajara
- HQ country
- Mexico
- HQ region
- Latin America
Offices20 records
Markets served
PiSA Pharmaceutical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Pharmaceutical Product Sales: Revenue from manufacturing and selling proprietary pharmaceutical and biotechnological products across 17 specialty lines, reaching both public (government) and private hospital and pharmacy channels in Mexico and internationally.
- Contract Manufacturing (Maquila): PiSA offers maquila (contract manufacturing) services to over 20 national and international pharmaceutical laboratories, providing manufacturing capacity, lower production costs, and coverage during plant maintenance periods. Served clients include Bayer, Sanofi-Aventis, Siegfried Rhein, Teleflex Medical, and others.
- International Expansion: Growing international revenue from product sales and distribution partnerships across Latin America and the Caribbean, including Colombia, El Salvador, Guatemala, Panama, Honduras, Chile, and exports to the United States.
Go-to-market motion2 records
Distribution channels6 records
Marketing channels4 records
PiSA Pharmaceutical product offering
Product offeringCore offering
PiSA Pharmaceutical manufactures more than 1,500 pharmaceutical and biotechnological product brands across 17 specialty lines at 14 production plants in Mexico, including injectable solutions, penicillin and cephalosporin antibiotics, lyophilized products, dental anesthetics, oral dosage forms, immunosuppressants, biotech products (vials, pre-filled syringes, cartridges), medical devices, and veterinary products. The company also provides maquila (contract manufacturing) services to over 20 national and international pharmaceutical laboratories, along with pharmacovigilance and tecnovigilance safety monitoring services.
Product overview
PiSA Farmacéutica is a Mexican pharmaceutical company operating as a multi-product manufacturer and contract service provider. The company operates 14 production plants and manufactures over 1,500 product brands across 17 specialty lines, employing approximately 30,000 collaborators. Its manufacturing portfolio includes injectable solutions (small and large volume parenterals), penicillin and cephalosporin antibiotics (aseptic powder filling), lyophilized products, dental anesthetics, oral forms (tablets, capsules, syrups), immunosuppressants, biotech products (vials, pre-filled syringes, dual-chamber cartridges), medical devices, and veterinary products. Complementing its own product lines, PiSA offers contract manufacturing (maquila) services to over 20 national and international pharmaceutical laboratories, encompassing product stability evaluation, analytical method development and validation, technical dossier preparation, and technology transfers. Additional services include pharmacovigilance and technovigilance reporting. Distribution is handled through a network of 7 regional distribution centers and a fleet of over 250 transport units serving Mexico, the United States, and Central/South American markets. A notable product-level partnership involves Cumberland Pharmaceuticals' ibuprofen injection distributed in Mexico.
Differentiator
Problem solved
Functional benefit
Products and services
- Injectables (Inyectables) Small-volume parenteral solutions (1 mL to 100 mL) in glass or plastic ampoules and vials, and large-volume parenteral solutions in plastic, glass, and PVC bags with capacities from 250 mL to 6,000 mL, manufactured for hospital and clinical use.
- Penicillin Products (Penicilínicos) Aseptic powder filling in glass vial containers ranging from 100 mg to 4,000 mg, manufactured as part of PiSA's penicillin antibiotics product line.
- Cephalosporin Products (Cefalosporínicos) Aseptic powder filling in glass vial containers from 100 mg to 4,000 mg, available in capsules and oral powders, manufactured as part of PiSA's cephalosporin antibiotics product line.
- Lyophilized Products (Liofilizados) Lyophilized products in glass vials, including pharmaceutical and oncological medications.
- Dental Anesthetics (Anestésicos Dentales) Dental anesthetics in plastic and glass cartridges.
- Oral Forms (Formas Orales) Tablets, capsules, caplets (dry or moisture-processed), film-coated pills, syrups, solutions, and oral suspensions.
- Immunosuppressants (Inmunosupresores) Immunosuppressant products in glass vials and tablets.
- Biotechnology Products (Biotecnológicos) Biotech products including vials (liquid and lyophilized), pre-filled syringes, single or dual-chamber cartridges (liquid or lyophilized), medical equipment, and veterinary products.
- Medical Equipment (Equipo Médico) Medical devices and equipment manufactured as part of the biotech product portfolio.
- Veterinary Products (Productos Veterinarios) Veterinary pharmaceutical products.
- Ibuprofen Injection Ibuprofen injection distributed in Mexico through a partnership with Cumberland Pharmaceuticals (a U.S. specialty pharmaceutical company).
- Maquila / Contract Manufacturing Services Contract manufacturing services for pharmaceutical and biotech products, including stability evaluation, analytical method development, validation, technical dossier preparation, and technology transfers, serving over 20 national and international pharmaceutical laboratories.
- Pharmacovigilance and Tecnovigilance (Farmacovigilancia y Tecnovigilancia) Monitoring and reporting services for adverse drug reactions and medical device safety, including detection, evaluation, understanding, and prevention of adverse effects, with an online reporting system for healthcare professionals and patients.
Quantifiable outcome
- 78 years of continuous pharmaceutical operations
- +2 more outcomes
Companies that use PiSA Pharmaceutical
Customer profileNamed customers9 records
Segments4 records
Ideal customer profiles4 records
PiSA Pharmaceutical technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature3 records
PiSA Pharmaceutical partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core and minor.
- KyndrylcoreKyndryl, the world's largest IT infrastructure services provider, partnered with PiSA Farmacéutica to support technology modernization of legacy SAP infrastructure on Google Cloud. This is part of Kyndryl's expanded partnership with Google Cloud to help enterprise customers modernize IT infrastructure, unlock data-driven insights, and advance AI-powered innovation. PiSA was cited as a case study for modernizing enterprise systems.
- Google CloudcoreGoogle Cloud partnered with Kyndryl to help PiSA Farmacéutica modernize its IT infrastructure, migrating legacy SAP systems to the cloud and leveraging AI capabilities. PiSA was used as a case study at Google Cloud Next 2026 demonstrating enterprise IT modernization in the pharmaceutical sector in Mexico.
- Cumberland PharmaceuticalscoreCumberland Pharmaceuticals partnered with PiSA Farmacéutica for the distribution of ibuprofen injection in Mexico. Cumberland Pharmaceuticals is a U.S. specialty pharmaceutical company that has expanded Vibativ into international markets including China, Saudi Arabia, and Jordan, with the PiSA partnership representing its entry into the Mexican market for ibuprofen injection.
- United NationsminorPiSA Farmacéutica adopted the United Nations Supplier Code of Conduct into its operational framework in March 2022, reaffirming its commitment to the highest international ethical and regulatory standards including human rights, labor rights, environmental protection, and anti-corruption principles.
- BayerminorBayer is served through PiSA's maquila (contract manufacturing) services, utilizing PiSA's manufacturing facilities and GMP-compliant production capacity.
- Sanofi-AventisminorSanofi-Aventis utilizes PiSA's contract manufacturing (maquila) services for pharmaceutical product manufacturing.
- Siegfried RheinminorSiegfried Rhein is among the pharmaceutical companies served through PiSA's maquila (contract manufacturing) services.
- Teleflex MedicalminorTeleflex Medical utilizes PiSA's contract manufacturing capabilities for medical devices and pharmaceutical products.
Scale indicators9 records
Recent moves8 records
Expansion highlights6 records
PiSA Pharmaceutical competitors and assessment
Company assessmentDirect peers
- Laboratorios Liomont: Mexican pharmaceutical manufacturer producing a wide range of generic and branded products across multiple therapeutic categories. Comparable in being a domestic Mexican manufacturer with broad generic and specialty product offerings.
- Genomma Lab Internacional: Mexican pharmaceutical company with broad OTC and generic product portfolio distributed across Mexico and Latin America. Comparable as a leading Mexican-origin pharma brand operator with similar multi-country LatAm commercial reach.
- Laboratorios Carnot: Latin American pharmaceutical manufacturer with a portfolio of branded generics, OTC, and specialty products across multiple therapeutic areas. Comparable as a LatAm-headquartered generic and specialty pharma manufacturer.
- Grupo Somar: Mexican pharmaceutical group with manufacturing and distribution operations across generics, specialty pharma, and personal care. Comparable as a Mexico-based multi-segment pharma manufacturer and distributor.
Emerging players
- Siegfried Holding: Swiss pharmaceutical CDMO offering API and finished-dose contract manufacturing services to global pharma companies. Comparable given PiSA's maquila business serving global pharma majors, including a relationship with Siegfried Rhein as a customer.
Broad incumbents
- Eurofarma Laboratórios: One of the largest pharmaceutical companies in Latin America, headquartered in Brazil, with broad generic, branded, and contract manufacturing operations. Comparable as a large LatAm pharma with diversified manufacturing and regional commercial reach.
- B. Braun: Global medical and pharmaceutical company with a large sterile injectables, IV solutions, and medical devices portfolio. Comparable in injectables manufacturing, medical device production, and as a counterparty for PiSA's maquila services.
- Sandoz: Global leader in generic and biosimilar pharmaceuticals with broad manufacturing footprint including sterile injectables. Comparable as a large-scale generic FDF manufacturer with a strong injectables portfolio.
- Teva Pharmaceutical Industries: World's largest generic pharmaceutical manufacturer with a broad portfolio across injectables, oral solids, and biosimilars. Comparable as a global generic FDF manufacturer competing in many of the same therapeutic categories.
- Aspen Pharmacare: South African-headquartered global specialty and generics manufacturer with strong presence across emerging markets including Latin America. Comparable as an emerging-market-focused generics manufacturer with international supply chain and sterile injectable capabilities.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
PiSA Pharmaceutical social profiles
Digital presencePiSA Pharmaceutical compliance and trust
Trust signalCompliance3 records
PiSA Pharmaceutical financial estimates
Financial estimateRevenue estimate
Valuation estimate
PiSA Pharmaceutical leadership team
Management profileNumber of profiles
Profiles6 records
PiSA Pharmaceutical subsidiaries and ownership
Company hierarchySubsidiaries6 records
PiSA Pharmaceutical funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
PiSA Pharmaceutical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about PiSA Pharmaceutical
What does PiSA Pharmaceutical do?
PiSA Pharmaceutical manufactures more than 1,500 pharmaceutical and biotechnological product brands across 17 specialty lines at 14 production plants in Mexico, including injectable solutions, penicillin and cephalosporin antibiotics, lyophilized products, dental anesthetics, oral dosage forms, immunosuppressants, biotech products (vials, pre-filled syringes, cartridges), medical devices, and veterinary products. The company also provides maquila (contract manufacturing) services to over 20 national and international pharmaceutical laboratories, along with pharmacovigilance and tecnovigilance safety monitoring services.
Is PiSA Pharmaceutical a public or private company?
PiSA Pharmaceutical is a private company. It is classified as family owned and is currently operating.
When was PiSA Pharmaceutical founded?
PiSA Pharmaceutical was founded in 1945. It employs 5,001 to 10,000 people.
Where is PiSA Pharmaceutical based?
PiSA Pharmaceutical is headquartered in Guadalajara, Mexico, in the Latin America region.
How does PiSA Pharmaceutical make money?
Three revenue lines are on record. Pharmaceutical Product Sales are the primary driver. The others are contract Manufacturing (Maquila) and international Expansion.
Who are PiSA Pharmaceutical's main competitors?
Direct peers on record are Laboratorios Liomont, Genomma Lab Internacional, Laboratorios Carnot and Grupo Somar. Siegfried Holding is listed as an emerging player. Broad incumbents are Eurofarma Laboratórios, B. Braun, Sandoz, Teva Pharmaceutical Industries and Aspen Pharmacare.
Does PiSA Pharmaceutical have an API?
No public API is recorded for PiSA Pharmaceutical.
What industry is PiSA Pharmaceutical in?
PiSA Pharmaceutical's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAIABAH, Generic Finished Dosage Form (FDF) Manufacturing, with a secondary code of HLAIABAJ, Generic ANDA/Regulatory Affairs & Submissions. Its NAICS code is 325412 and its SIC code is 2834.